Xencor
XNCR
$24.11
Share price
2.03%
Change (1 day)
-12.77%
Change (1 year)
Categories
Xencor (XNCR) - P/B ratio
P/B ratio as of May 2024 : 2.18
According to Xencor's latest financial reports the company has a price-to-book ratio of 2.18.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Xencor - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.93 | -9.95% |
| 2022-12-31 | 2.14 | -32.94% |
| 2021-12-31 | 3.20 | -26.95% |
| 2020-12-31 | 4.38 | 32.75% |
| 2019-12-31 | 3.30 | -15.44% |
| 2018-12-31 | 3.90 | 19.93% |
| 2017-12-31 | 3.25 | -16.4% |
| 2016-12-31 | 3.89 | 6.6% |
| 2015-12-31 | 3.65 | -57.08% |
| 2014-12-31 | 8.50 | 118.2% |
| 2013-12-31 | 3.90 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.25 | 140.98% | 🇺🇸 USA |
 AbbVie ABBV | 27.4 | 1,157.97% | 🇺🇸 USA |
 Amgen AMGN | 24.0 | 1,000.60% | 🇺🇸 USA |
 Merck MRK | 8.63 | 296.53% | 🇺🇸 USA |
 Seagen
SGEN | 16.9 | 677.23% | 🇺🇸 USA |
 MacroGenics MGNX | 6.24 | 186.59% | 🇺🇸 USA |